The Value Of Integrated R&D Sites
Executive Summary
What many high performing R&D organizations also share are fully integrated R&D sites, often in close vicinity to academic hotbeds
You may also be interested in...
Making The Grade? Big Pharma Deals With Academia Begin To Score
With three to four years in the books, Big Pharma’s updated tie-ups with academia have started to progress – some have even reached first-in-human stages, but these updated models have yet to produce any radical results that show they are an improvement over old-style partnerships.
Scalable Models For High-Performance Pharma R&D
The superior R&D and growth performance of mid-sized companies like Celgene, Gilead, or Biogen can be attributed to a number of factors such as the size of the R&D budget, portfolio focus, a good mix of internal and external innovation sourcing, but most importantly a strong culture, leadership, and the ability to attract the right people. Part 3 of Catenion’s review of pharma R&D productivity.
J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Need a specific report? 1000+ reports available
Buy Reports